| CAS登錄號 | 中文名 | 英文名 | 分子結構式 | 分子式 | 詳情 | 供應商 |
| 119694-67-6 | Hydrazinecarbothioamide,2-(9H-pyrido[3,4-b]indol-3-ylmethylene)-; 9H-Pyrido[3,4-b]indole,hydrazinecarbothioamide deriv. |  | C13H11N5S | 詳情 | 供應商 | |
| 22102-92-7 | Hexanoic acid,2,5-dioxo-1-pyrrolidinyl ester; 2,5-Pyrrolidinedione,1-[(1-oxohexyl)oxy]- (9CI); Succinimide, N-(hexanoyloxy)- (8CI); N-(Hexanoyloxy)succinimide |  | C10H15NO4 | 詳情 | 供應商 | |
| 5462-54-4 | Hydrazinecarboxamide,2-[(4-hexyl-2,5-dioxo-4-imidazolidinyl)methylene]-; 4-Imidazolidinecarboxaldehyde,4-hexyl-2,5-dioxo-, semicarbazone (8CI); NSC 23153 |  | C11H19N5O3 | 詳情 | 供應商 | |
| 167425-44-7 | Helicokinin II (9CI); Glycinamide,L-valyl-L-arginyl-L-phenylalanyl-L-seryl-L-prolyl-L-tryptophyl-; Hez-Kinin II |  | C41H58N12O8 | 詳情 | 供應商 | |
| 102339-00-4 | Hydrazinecarboxamide,N-(4-chlorophenyl)-2-formyl-; NSC 664254 |  | C8H8ClN3O2 | 詳情 | 供應商 | |
| 24898-59-7 | Hydrazinecarbothioamide,N-(2-hydroxyethyl)-2-(1-isoquinolinylmethylene)-; Isoquinaldaldehyde,4-(2-hydroxyethyl)-3-thiosemicarbazone (8CI); Semicarbazide, 4-(2-hydroxyethyl)-1-(1-isoquinolylmethylene)-3-thio-(8CI); A 201 |  | C13H14N4OS | 詳情 | 供應商 | |
| 1608-78-2 | Heptanedioic acid,3-oxo-; 3-Ketoheptanedioicacid; 3-Oxo-1,7-heptanedioic acid; b-Ketopimelic acid |  | C7H10O5 | 詳情 | 供應商 | |
| 28069-16-1 | Hypoxanthine, 9-b-D-xylofuranosyl-,2',3',5'-triacetate (8CI); NSC83296 |  | C16H18N4O8 | 詳情 | 供應商 | |
| 110576-19-7 | Hydrazinecarboxamide,2-(5H-indeno[1,2-b]pyridin-5-ylidene)-; 5H-Indeno[1,2-b]pyridine,hydrazinecarboxamide deriv. |  | C13H10N4O | 詳情 | 供應商 | |
| 135-54-6 | Hydrazine,[(2,5-dimethoxyphenyl)methyl]-; Hydrazine,(2,5-dimethoxybenzyl)- (7CI,8CI); 2,5-Dimethoxybenzylhydrazine |  | C9H14N2O2 | 詳情 | 供應商 | |
| 126775-74-4 | Himastatin (9CI); D-Threonine,1,1'-[(1,1',2,2',3,3',3a,3'a,8,8',8a,8'a-dodecahydro-3a,3'a-dihydroxy[5,5'-bipyrrolo[2,3-b]indole]-2,2'-diyl)dicarbonyl]bis[D-valyl-3-methyl-L-2-hydroxybutanoyl-cis-5-hydroxy-D-hexahydro-3-pyridazinecarbonyl-L-leucyl-,cyclic (5® 1),(5'® 1')-bis(peptide), [2S-[2a,3aa,5(2'R*,3'aS*,8'aR*),8aa]]-; Antibiotic BMY 40800; D-Threonine,(2S,2'S,3aR,3'aR,8aS,8'aS)-1,1',2,2',3,3',3a,3'a,8,8',8a,8'a-dodecahydro-3a,3'a-dihydroxy[5,5'-bipyrrolo[2,3-b]indole]-2,2'-dicarbonylbis[D-valyl-(2S)-2-hydroxy-3-methylbutanoyl-(3R,5R)-hexahydro-5-hydroxy-3-pyridazinecarbonyl-L-leucyl-,(6® 11),(6'® 11')-dilactam |  | C72H104N14O20 | 詳情 | 供應商 | |
| 10021-65-5 | Hexanenitrile,2-hydroxy-, (2R)-; Hexanenitrile,2-hydroxy-, (R)-; Hexanenitrile, 2-hydroxy-, D-(+)- (8CI) |  | C6H11NO | 詳情 | 供應商 | |
| 38207-56-6 | Hexanediamide,N1,N6-didocosyl-; Hexanediamide,N,N'-didocosyl- (9CI) |  | C50H100N2O2 | 詳情 | 供應商 | |
| 5425-39-8 | Hydrazinecarbothioamide,2-[(2,5-dichloro-3-thienyl)methylene]-; 3-Thiophenecarboxaldehyde,2,5-dichloro-, thiosemicarbazone (8CI); NSC 12756 |  | C6H5Cl2N3S2 | 詳情 | 供應商 | |
| 27421-66-5 | Hydrazinecarbothioamide,2-(diphenylmethylene)-N-methyl-; Benzophenone,4-methyl-3-thiosemicarbazone (8CI); Semicarbazide,1-(diphenylmethylene)-4-methyl-3-thio- (8CI); NSC 143168 |  | C15H15N3S | 詳情 | 供應商 | |
| 35490-05-2 | Hexanoic acid,2-acetyl-5-oxo-, ethyl ester; Ethyl2-acetyl-5-oxohexanoate |  | C10H16O4 | 詳情 | 供應商 | |
| 869-17-0 | Hydrazinecarboximidamide,2,2'-[1-(trifluoromethyl)-1,2-ethanediylidene]bis- (9CI); Guanidine,1,1'-[[(trifluoromethyl)ethanediylidene]dinitrilo]di- (8CI) |  | C5H9F3N8 | 詳情 | 供應商 | |
| 88096-03-1 | Homocysteine,S-(3-carboxypropyl)-; DL-Homocysteine,S-(3-carboxypropyl)- |  | C8H15NO4S | 詳情 | 供應商 | |
| 376-53-4 | Hexanedinitrile,2,2,3,3,4,4,5,5-octafluoro-; Hexanedinitrile,octafluoro- (7CI,8CI,9CI); Octafluoroadiponitrile; Perfluoroadipic aciddinitrile; Perfluoroadiponitrile |  | C6F8N2 | 詳情 | 供應商 | |
| 25354-61-4 | Hexadecanoic acid,2,2-bis(hydroxymethyl)-1,3-propanediyl ester (9CI); Palmiticacid, 2,2-bis(hydroxymethyl)trimethylene ester (6CI,8CI); Pentaerythritol,dipalmitate (7CI) |  | C37H72O6 | 詳情 | 供應商 | |